SMARTPRACTICE DENMARK ApS: Financial statements 2024
CVR: 89669510
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SMARTPRACTICE DENMARK ApS (CVR 89669510) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 76,929,990 and a net result of DKK 19,667,222 compared with DKK 17,866,197 the year before. That is an increase of 3.7% compared with the year before. The profit margin was 25.6%. Equity in the 2024 report amounted to DKK 48,508,814. The solvency ratio was 45.1%. The company had 48 employees in the financial year.
- Revenue
- DKK 76,929,990
- Gross Profit
- DKK 38,775,874
- Profit/Loss
- DKK 19,667,222
- Equity
- DKK 48,508,814
- Total Assets
- DKK 107,548,323
- Employees
- 48
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 76.9 mio. | 38.8 mio. | 19.7 mio. | 48.5 mio. | 48 |
| 2023 | 74.2 mio. | 37.2 mio. | 17.9 mio. | 48.8 mio. | 47 |
| 2022 | 69.5 mio. | 35.4 mio. | 15.8 mio. | 31 mio. | 45 |
| 2021 | 59.4 mio. | 29.2 mio. | 13 mio. | 30.2 mio. | 42 |
| 2020 | 49.2 mio. | 16.2 mio. | 2.6 mio. | 17.2 mio. | 42 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of May 1, 2024, Anders Handlos Grauslund is registered as director of SMARTPRACTICE DENMARK ApS.
SMARTPRACTICE DENMARK ApS has published its annual report for 2023. Revenue came to DKK 74,207,307, and the net result was DKK 17,866,197.
As of January 31, 2024, Stefania Cianci has joined the board of directors of SMARTPRACTICE DENMARK ApS.
As of January 31, 2024, Karl Michael Klenk is registered as director of SMARTPRACTICE DENMARK ApS.
As of January 31, 2024, Michael Nielsen has stepped down as director of SMARTPRACTICE DENMARK ApS.
About SMARTPRACTICE DENMARK ApS
SMARTPRACTICE DENMARK ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 1979. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MEKOS LABORATORIES ApS and MEKOS LABORATORIES A/S. The management consists of Anders Handlos Grauslund and Stefania Cianci. The board consists of Curtis Peter Hamann (chair), Beth Rhode Hamann, Randy Owen Burger and Stefania Cianci. The company is owned by Allerderm Laboratories. The company has 43 employees (2018). In 2025, the company reported revenue of DKK 78,486,567 and a net result of DKK 16,873,959 compared with DKK 19,667,222 the year before. Equity in the 2025 report amounted to DKK 47,382,773.